(Q40877850)

24 September 2017

1 reference

title

Applying radiobiological principles to combined modality treatment of head and neck cancer--the time factor (English)

1 reference

24 September 2017

Applying radiobiological principles to combined modality treatment of head and neck cancer—The time factor (English)

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(97)00466-5

24 November 2024

1

Peters LJ

1 reference

24 September 2017

H. R. Withers

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9369130

24 November 2024

language of work or name

English

0 references

publication date

1 November 1997

1 reference

full work available at URL

24 September 2017

https://api.elsevier.com/content/article/PII:S0360301697004665?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(97)00466-5

https://api.elsevier.com/content/article/PII:S0360301697004665?httpAccept=text/plain

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(97)00466-5

International Journal of Radiation Oncology Biology Physics

24 November 2024

published in

1 reference

24 September 2017

volume

39

1 reference

24 September 2017

issue

4

1 reference

24 September 2017

page(s)

831-836

1 reference

Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: influence of tumour proliferation

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900466-5

7 January 2021

Resection of advanced cervical metastasis prior to definitive radiotherapy for primary squamous carcinomas of the upper aerodigestive tract

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900466-5

7 January 2021

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900466-5

7 January 2021

Overview of combined modality therapies for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900466-5

7 January 2021

Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900466-5

7 January 2021

Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900466-5

7 January 2021

[Perioperative chemotherapy of squamous cell carcinoma of the hypopharynx]

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900466-5

7 January 2021

An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900466-5

7 January 2021

The influence of stress and stress hormones on the transplantability of a non-immunogenic syngeneic murine tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900466-5

7 January 2021

Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900466-5

7 January 2021

Evaluation of the dose for postoperative radiation therapy of head and neck cancer: First report of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900466-5

7 January 2021

Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900466-5

7 January 2021

Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900466-5

7 January 2021

Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900466-5

7 January 2021

Combined modality treatment with radiotherapy and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900466-5

7 January 2021

A prospective trial of accelerated radiotherapy in the postoperative treatment of high-risk squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900466-5

7 January 2021

Failure in the neck following multimodality treatment for advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900466-5

7 January 2021

Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: Patterns of fractionation study of radiobiology

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900466-5

7 January 2021

Local control of carcinoma of the tonsil by radiation therapy: An analysis of patterns of fractionation in nine institutions

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900466-5

7 January 2021

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900466-5

7 January 2021

Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900466-5

7 January 2021

Accelerated fractionation using the concomitant boost: a contribution of radiobiology to radiotherapy

series ordinal

19

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(97)00466-5

24 November 2024

Identifiers

1 reference

24 September 2017

1 reference